Tuesday, July 23, 2013 1:29:42 PM
I have been here for years, but silent. I just felt confidence was high, the NNVC presentations were good and that is why I started to post.
NNVC has being managed well. They have the money that will get them through Phase I/II next year. Yes, in recent past there have been delays, but now there is a well seasoned Project Management group in place, managing activities on a timeline. The catalysts/events/objectives are NNVC's objectives/goals that they have outlined in their NNVC-RedChip video. Have a little faith (not blind faith), their promises will be fulfilled according to their outlined plan (barring the meddlers, the world improvers, (ahem) bureaucrats)
You may be trading NNVC and that is good, it is your prerogative. Others, like myself, are patiently holding and confident on the science behind this NNVC "Express".
Nanotechnology, as far as we know, has its origins in 1959 when first discussed by renowned physicist Richard Feynman in his talk "There's Plenty of Room at the Bottom", in which he described the possibility of synthesis via direct manipulation of atoms.
http://www.popularmechanics.com/technology/engineering/extreme-machines/advanced-3d-printer-creates-nano-indycar-7358796
The advent of computers/microcomputers has made possible to turn raw data into usable information fast, tool/utilities have been developed and in turn they have accelerated all kinds of new discoveries and potential breakthroughs scientists are about to unveil.
Look, I feel the dated table of events I posted could be adjusted (those that I guesstimated, not explicitly shown in the video) but adjustments, if any, will be minor because the Project Management group is getting good input information from everyone else in the company and that is why they publish the outlined objectives we saw in the NNVC-RedChip video.
If you want, post yours out there and we will see in time which are more accurate. Information, specially good information that comes now from the NNVC CEO, will bring certainty, confidence and resistance/shorts will be out of the way, soon, very soon.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM